FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3790511000001100: Pentazocine 25mg tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21797701000001116 Pentazocine 25mg tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21797801000001113 Pentazocine 25mg tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pentazocine 25mg tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register Exempt Safe Custody) true Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet Is pack of Product containing precisely pentazocine hydrochloride 25 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet Has active ingredient Pentazocine hydrochloride false Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet Has active ingredient Opiate agonist-antagonist false Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet Has active ingredient Substance with opioid receptor partial agonist mechanism of action false Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet Has VMP Product containing precisely pentazocine hydrochloride 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet Has specific active ingredient Pentazocine hydrochloride true Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pentazocine 25mg tablets (Zentiva Pharma UK Ltd) 100 tablet Is a True Pentazocine 25mg tablets 100 tablet Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets (Unichem Plc) 100 tablet Is a True Pentazocine 25mg tablets 100 tablet Inferred relationship Existential restriction modifier
Fortral 25mg tablets (Zentiva Pharma UK Ltd) 100 tablet Is a True Pentazocine 25mg tablets 100 tablet Inferred relationship Existential restriction modifier
Pentazocine 25mg tablets (Kent Pharma (UK) Ltd) 100 tablet Is a True Pentazocine 25mg tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start